S protein represents the primary target of currently approved COVID-19 vaccines, being responsible for the virus’s entry into the host cells after binding with the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of epithelial cells, especially in lungs and bronchial and nasal epithelia [18,19]. The gene discussed is ACE2; the disease is COVID-19.